Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

The Cost of Breast Cancer Screening in the Medicare Population

The Cost of Breast Cancer Screening in the Medicare Population ORIGINAL INVESTIGATION HEALTH CARE REFORM The Cost of Breast Cancer Screening in the Medicare Population Cary P. Gross, MD; Jessica B. Long, MPH; Joseph S. Ross, MD, MHS; Maysa M. Abu-Khalaf, MD; Rong Wang, PhD; Brigid K. Killelea, MD, MPH; Heather T. Gold, PhD; Anees B. Chagpar, MD, MA, MPH, MSc; Xiaomei Ma, PhD Background: Little is known about the cost to Medi- respectively. For women 75 years or older, annual screen- care of breast cancer screening or whether regional- ing-related expenditures exceeded $410 million. Age- level screening expenditures are associated with cancer standardized screening-related cost per beneficiary varied stage at diagnosis or treatment costs, particularly be- more than 2-fold across regions (from $42 to $107 per cause newer breast cancer screening technologies, like beneficiary); digital screening mammography and CAD digital mammography and computer-aided detection accounted for 65% of the difference in screening-related (CAD), have diffused into the care of older women. cost between HRRs in the highest and lowest quartiles of cost. Women residing in HRRs with high screening Methods: Using the linked Surveillance, Epidemiol- costs were more likely to be diagnosed as having early- ogy, and End Results–Medicare database, we identified stage cancer (incidence rate ratio, 1.78 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

The Cost of Breast Cancer Screening in the Medicare Population

Download PDF
9 pages
Read Article

Loading next page...
 
/lp/american-medical-association/the-cost-of-breast-cancer-screening-in-the-medicare-population-G8CV8Qg8tL
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2013.1397
pmid
23303200
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION HEALTH CARE REFORM The Cost of Breast Cancer Screening in the Medicare Population Cary P. Gross, MD; Jessica B. Long, MPH; Joseph S. Ross, MD, MHS; Maysa M. Abu-Khalaf, MD; Rong Wang, PhD; Brigid K. Killelea, MD, MPH; Heather T. Gold, PhD; Anees B. Chagpar, MD, MA, MPH, MSc; Xiaomei Ma, PhD Background: Little is known about the cost to Medi- respectively. For women 75 years or older, annual screen- care of breast cancer screening or whether regional- ing-related expenditures exceeded $410 million. Age- level screening expenditures are associated with cancer standardized screening-related cost per beneficiary varied stage at diagnosis or treatment costs, particularly be- more than 2-fold across regions (from $42 to $107 per cause newer breast cancer screening technologies, like beneficiary); digital screening mammography and CAD digital mammography and computer-aided detection accounted for 65% of the difference in screening-related (CAD), have diffused into the care of older women. cost between HRRs in the highest and lowest quartiles of cost. Women residing in HRRs with high screening Methods: Using the linked Surveillance, Epidemiol- costs were more likely to be diagnosed as having early- ogy, and End Results–Medicare database, we identified stage cancer (incidence rate ratio, 1.78

Journal

JAMA Internal Medicine – American Medical Association

Published: Feb 11, 2013

References

  • Limits on Medicare's ability to control rising spending on cancer drugs.
    Bach, PB
  • Costs of cancer care: a view from the Centers for Medicare and Medicaid services.
    Bach, PB
  • Evaluation of trends in the cost of initial cancer treatment.
    Warren, JL; Yabroff, KR; Meekins, A; Topor, M; Lamont, EB; Brown, ML
  • Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer.
    Koroukian, SM; Bakaki, PM; Schluchter, MD; Owusu, C
  • Screening for breast cancer: an update for the US Preventive Services Task Force.
    Nelson, HD; Tyne, K; Naik, A; Bougatsos, C; Chan, BK; Humphrey, L
  • Diffusion of computer-aided mammography after mandated Medicare coverage.
    Fenton, JJ; Foote, SB; Green, P; Baldwin, LM
  • How widely is computer-aided detection used in screening and diagnostic mammography?
    Rao, VM; Levin, DC; Parker, L; Cavanaugh, B; Frangos, AJ; Sunshine, JH
  • Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis.
    Noble, M; Bruening, W; Uhl, S; Schoelles, K
  • Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
    Berg, WA; Zhang, Z; Lehrer, D
  • Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner, E; Plewes, DB; Hill, KA
  • Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
    Leach, MO; Boggis, CR; Dixon, AK
  • Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl, CK; Schrading, S; Leutner, CC
  • Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
    Kriege, M; Brekelmans, CT; Boetes, C
  • Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
    Berg, WA; Blume, JD; Cormack, JB
  • Potential for cancer related health services research using a linked Medicare-tumor registry database.
    Potosky, AL; Riley, GF; Lubitz, JD; Mentnech, RM; Kessler, LG
  • Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
    Warren, JL; Klabunde, CN; Schrag, D; Bach, PB; Riley, GF
  • Comorbidity measures for use with administrative data.
    Elixhauser, A; Steiner, C; Harris, DR; Coffey, RM
  • Coding algorithms for defining comorbidities in ICD-9-CMand ICD-10administrative data.
    Quan, H; Sundararajan, V; Halfon, P
  • Development of a comorbidity index using physician claims data.
    Klabunde, CN; Potosky, AL; Legler, JM; Warren, JL
  • Studying radiation therapy using SEER-Medicare-linked data.
    Virnig, BA; Warren, JL; Cooper, GS; Klabunde, CN; Schussler, N; Freeman, J
  • Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data: Surveillance, Epidemiology and End Results.
    Du, X; Freeman, JL; Goodwin, JS
  • International Classification of Diseases, Ninth Revision, Clinical Modification.
  • 2002 International Classification of Diseases, Ninth Revision, Clinical Modification, Volumes 1, 2, and 3, and Healthcare Common Procedure Coding System, Level II.
    Buck, CJ
  • Physicians' Current Procedural Terminology.
    Kirschner, CG; Edwards, NK; May, DM
  • Current Procedural Terminology CPT 2002.
    Anderson, CA; Beebe, M; Dalton, JA
  • Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman, R; Quale, C; Chu, PW; Rosenberg, R; Kerlikowske, K
  • Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown, ML; Riley, GF; Schussler, N; Etzioni, R
  • Core-needle and surgical breast biopsy: comparison of three methods of assessing cost.
    Burkhardt, JH; Sunshine, JH
  • Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
    Riley, GF; Potosky, AL; Lubitz, JD; Kessler, LG
  • Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings.
    Warren, JL; Brown, ML; Fay, MP; Schussler, N; Potosky, AL; Riley, GF
  • Cost of care for elderly cancer patients in the United States.
    Yabroff, KR; Lamont, EB; Mariotto, A
  • Medicare Enrollment Table 2.2: Total, Fee-for-Service and Managed Care Enrollees, by Demographic Characteristics as of July, 2007.
  • Surveillance, Epidemiology, and End Results.
  • Center for the Evaluative Clinical Sciences. The Dartmouth Atlas of Health Care.
  • Dartmouth Atlas of Health Care.
  • Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer.
    Lewin, JM; D’Orsi, CJ; Hendrick, RE
  • Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study.
    Skaane, P; Hofvind, S; Skjennald, A
  • Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate.
    Taylor, P; Potts, HWW
  • Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager, M; Adami, H-O; Bretthauer, M; Tamimi, RM
  • Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST.
    Pisano, ED; Hendrick, RE; Yaffe, MJ
  • Screening mammography: costs and use of screening-related services.
    Poplack, SP; Carney, PA; Weiss, JE; Titus-Ernstoff, L; Goodrich, ME; Tosteson, AN
  • Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations.
    Bach, PB; Guadagnoli, E; Schrag, D; Schussler, N; Warren, JL

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial